Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

ClinicalTrials.gov ID: NCT02992132

Public ClinicalTrials.gov record NCT02992132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy of pimavanserin compared with placebo in treatment of agitation and aggression after 12 weeks of treatment

Study identification

NCT ID
NCT02992132
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
111 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2016 (Type not available)
Primary completion
Jan 25, 2018 (Actual)
Completion
Feb 16, 2018 (Actual)
Last update posted
Mar 28, 2019

2016 – 2018

United States locations

U.S. sites
33
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Not listed Costa Mesa California 92626 —
Not listed Fresno California 93710 —
Not listed Fullerton California 92835 —
Not listed Los Angeles California 90073 —
Not listed Pasadena California 91105 —
Not listed San Diego California 92103 —
Not listed Danbury Connecticut 06810 —
Not listed Washington D.C. District of Columbia 20007 —
Not listed Boca Raton Florida 33486 —
Not listed Deerfield Beach Florida 33064 —
Not listed Miami Florida 33137 —
Not listed Naples Florida 34102 —
Not listed Atlanta Georgia 30322 —
Not listed Bangor Maine 04401 —
Not listed Quincy Massachusetts 02169 —
Not listed Clinton Township Michigan 48035 —
Not listed Flowood Mississippi 39232 —
Not listed Jackson Mississippi 39216 —
Not listed Eatontown New Jersey 07724 —
Not listed Marlton New Jersey 08053 —
Not listed Toms River New Jersey 08755 —
Not listed Albuquerque New Mexico 87131 —
Not listed Charlotte North Carolina 28270 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Medford Oregon 97504 —
Not listed Jenkintown Pennsylvania 19046 —
Not listed Norristown Pennsylvania 19401 —
Not listed Willow Grove Pennsylvania 19090 —
Not listed Charleston South Carolina 29401 —
Not listed Nashville Tennessee 37212 —
Not listed DeSoto Texas 75115 —
Not listed Salt Lake City Utah 84124 —
Not listed Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02992132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2019 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02992132 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →